1. New developments in the pathology of malignant lymphoma. A review of the literature published from January–April 2016
   J. Han van Krieken, 2016, Journal of Hematopathology CrossRef
2. A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
   Saerok Shim et al, 2022, Frontiers in Immunology CrossRef
3. A systematic review of primary gastric diffuse large B-cell lymphoma: Clinical diagnosis, staging, treatment and prognostic factors
   Zhimin Bai et al, 2021, Leukemia Research CrossRef
4. Interleukin 32, inflammation and cancer
   Jin Tae Hong et al, 2017, Pharmacology & Therapeutics CrossRef
5. Insights into the role of IL-32 in cancer
   Yvette J.E. Sloot et al, 2018, Seminars in Immunology CrossRef
6. Focusing on Helicobacter pylori infection in the elderly
   Hang Gong et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
7. IL-32 and its paradoxical role in neoplasia
   Jacob T. Hough et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
8. Elevated Gene Expression of Interleukin-32 Isoforms Alpha, Beta, Gamma, and Delta in the Peripheral Blood of Chronic Psoriatic Patients
   Hani Al-Shobaili et al, 2018, Diseases CrossRef
9. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
   Sandra Ramos-Inza et al, 2021, Journal of Medicinal Chemistry CrossRef
10. Molecular interactions and functions of IL-32
    Kristin Roseth Aass et al, 2021, Journal of Leukocyte Biology CrossRef